← Back to Search

CEUS for Spinal Cord Injury

N/A
Recruiting
Led By Brian F Saway, MD
Research Sponsored by Medical University of South Carolina
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up clinical monitoring (12 months)
Awards & highlights

Study Summary

This trial is testing whether using a contrast enhanced ultrasound (CEUS) can help predict and prevent post-operative deficits from spinal cord injury in patients who have had decompression surgery for chronic compression.

Who is the study for?
This trial is for adults aged 18-80 who are scheduled for posterior cervicothoracic decompression surgery to treat spinal cord compression. It's not suitable for those allergic to perflutren lipid microsphere or its components, pregnant individuals, patients with prior surgery at the same spot, or anyone unable to consent due to physical/cognitive reasons.Check my eligibility
What is being tested?
The study tests if a contrast agent called Definity Perflutren Lipid Microsphere Ultrasound Contrast can help visualize blood flow changes in the spine during surgery. The goal is to see if it predicts and shows recovery from spinal cord injuries better than current methods.See study design
What are the potential side effects?
Potential side effects may include reactions related to hypersensitivity such as itching, swelling, or difficulty breathing especially in those with known allergies to any of the contrast agent's components.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~clinical monitoring (12 months)
This trial's timeline: 3 weeks for screening, Varies for treatment, and clinical monitoring (12 months) for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Spinal Cord
Secondary outcome measures
Perfusion (procedure)

Trial Design

1Treatment groups
Experimental Treatment
Group I: Contrast Enhanced Ultrasound ArmExperimental Treatment1 Intervention

Find a Location

Who is running the clinical trial?

Medical University of South CarolinaLead Sponsor
932 Previous Clinical Trials
7,394,370 Total Patients Enrolled
South Carolina Spinal Cord Injury Research FundUNKNOWN
Brian F Saway, MDPrincipal InvestigatorMedical University of South Carolina

Media Library

Definity Perflutren Lipid Microsphere Ultrasound Contrast Clinical Trial Eligibility Overview. Trial Name: NCT05530798 — N/A
Spinal Cord Injury Research Study Groups: Contrast Enhanced Ultrasound Arm
Spinal Cord Injury Clinical Trial 2023: Definity Perflutren Lipid Microsphere Ultrasound Contrast Highlights & Side Effects. Trial Name: NCT05530798 — N/A
Definity Perflutren Lipid Microsphere Ultrasound Contrast 2023 Treatment Timeline for Medical Study. Trial Name: NCT05530798 — N/A

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Are there any requirements to enroll in this research program?

"Our team is looking for 20 individuals, aged 18-80, who have been diagnosed with spinal stenosis and are scheduled for posterior cervicothoracic decompression surgery."

Answered by AI

Are there any available slots for this research project?

"According to the latest information on clinicaltrials.gov, this particular trial is not looking for patients at the moment. The listing was originally created on October 1st, 2020 but has since been updated September 6th of this year. Even though this study isn't recruiting right now, there are plenty of other options available with 1084 trials currently enrolling patients."

Answered by AI

Does this test require participants to be a certain age?

"From the information available, it seems that eligible patients for this trial must be between 18 and 80 years old. Out of all the similar clinical trials, 147 are only for people under 18 and 903 are specifically for individuals over 65."

Answered by AI
~10 spots leftby Oct 2024